Model-based AI to de-risk and accelerate the development of
• DTx ,
• digital biomarkers , and
• digital clinical measures .
Bringing preclinical rigor to digital health—fast, explainable, and designed for differentiation and IP protection.
From pharma standards to digital health strategy—customized for your pipeline.
Design smarter trials with virtual patients.
Real-time insight from virtual patient models.